Hematologic Pathophysiology Hemoglobin Disorders Flashcards
Hemoglobin is a large molecule made up of
proteins & iron
four folded chains of a protein called globin
An individual erythrocyte may contain about
300 million hemoglobin molecules
Hemoglobin A is most common & made up of
2 alpha and 2 beta
Describe the formation of hemoglobin:
synthesis begins in the proerythroblast & continues through the reticulocyte stage
2 succinyl-CoA (formed in the Kreb cycle) + 2 glycine–> pyrrole molecule
4 pyrrole molecules combine to form protoporphyrin which combines with iron to make heme
Heme + globin combine
4 subunit chains possible (alpha, beta, gamma, and delta)
In the lungs, hemoglobin picks up
oxygen, which binds to the iron ions, forming oxyhemoglobin
The bright red, oxygenated hemoglobin travels to the body tissues, where it
releases some of the oxygen molecules, becoming darker red deoxyhemoglobin
Oxygen release depends on the need for
oxygen in the surrounding tissues
Each hemoglobin chain has a heme prosthetic group containing an atom of
iron
There are _________ in each hemoglobin and therefore _____ in each hemoglobin molecule
4 hemoglobin chains; 4 iron atoms
Each of the irons can bind loosely with
oxygen (O2) making a total of 8 oxygen atoms
The type of hemoglobin chain in the hemoglobin molecule determines the
binding affinity for oxygen
The oxygen combining capacity is directly related to
hemoglobin concentration and not on the number of RBCs
The shape of the hemoglobin O2 dissociation curve is
sigmoidal due to cooperative binding of oxygen to hemoglobin
Lifespan of the RBC is
120 days
When the RBC dies, _____ is released
hemoglobin
liver Kupffer cells phagocytose the hemoglobin
Describe the destruction of hemoglobin.
hemoglobin opens up--> releases iron & heme iron is released back into the blood & carried by transferrin to bone marrow for production of new RBCs or to the liver to be store Porphyrin portion (pyrrole rings) of hemoglobin are converted to biliverdin & then unconjugated bilirubin
Disorders of hemoglobin that are commonly clinically significant include:
methemoglobin- altered affinity
thalassemia- quantitative disorder of globin chain
sickle cell disease- qualitative disorder of globin structure
Methemoglobin is formed when the
iron in hemoglobin is oxidized from the ferrous (Fe2+) to the ferric (Fe3+) state
ic=ick= it’s not a good state
Methemoglobin cannot bind
oxygen and therefore cannot carry oxygen to the tissues
Normally <1% of a person’s hemoglobin in
methemoglobin
In situations of excess methemoglobin, the blood becomes
dark blue/brown
The NADH dependent enzyme_______ is responsible for converting Mhgb back to Hgm
methemoglobin reductase
The methemoglobin reductase pathway uses
nicotinamide adenine dinucleotide (NADH)- cytochrome b5 reductase in the erythrocyte from anaerobic glycolysis to maintain heme iron in its ferrous state
How does methemoglobin move the oxyhemoglobin dissociation curve?
moves the curve markedly to the left & therefore delivers little O2 to the tissues
increased affinity in the remaining heme sites that are in the ferrous state
Patients can tolerate methemoglobin up to
30%
Between 30-50% of methemoglobin,
30-50% symptoms of oxygen deprivation occur- muscle weakness, nausea, tachycardia
> 50% of methemoglobin leads to
coma & death
Describe the three mechanisms of methemoglobinemia:
Congenital:
1. globin chain mutation (HbM)
2. methemoglobin reductase system mutation
Acquired
3. toxic exposure to substance that oxidizes normal Hb iron that exceeds the normal capacity
For patients with the globin chain mutation, the patient’s blood will
be a brownish blue color & will have a cyanotic appearance
Describe how the globin chain mutation causes methemoglobinemia.
Mutations that stabilize heme iron in the ferric (Fe3+) state, making it relatively resistant to reduction by the methemoglobin reductase system
Patients who have globin chain mutation are often
asymptomatic as their methemoglobin levels rarely exceed 30% of total Hb unless exposed to a toxic dose of oxidizing agent
For patients with impaired reductase system methemoglobinemia, exposure to
agents that oxidize hemoglobin can produce a life-threatening methemoglobinemia